Your browser doesn't support javascript.
loading
A simplified prognostic score for T-cell large granular lymphocyte leukaemia.
Liu, Hailing; Guo, Jingjing; Cao, Lei; Zhu, Huayuan; Miao, Yi; Du, Xinyi; Wu, Yujie; Xu, Wei; Li, Jianyong; Fan, Lei.
Affiliation
  • Liu H; Department of Hematology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.
  • Guo J; Department of Geriatric, Nanjing Second Hospital, Nanjing University of Chinese Medicine, Nanjing, China.
  • Cao L; Department of Hematology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.
  • Zhu H; Department of Hematology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.
  • Miao Y; Department of Hematology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.
  • Du X; Department of Hematology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.
  • Wu Y; Department of Hematology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.
  • Xu W; Department of Hematology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.
  • Li J; Department of Hematology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.
  • Fan L; Department of Hematology, Jiangsu Province Hospital and Nanjing Medical University First Affiliated Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China.
Ann Med ; 55(2): 2258899, 2023.
Article in En | MEDLINE | ID: mdl-37801616
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Large Granular Lymphocytic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Middle aged Language: En Journal: Ann Med Journal subject: MEDICINA Year: 2023 Document type: Article Affiliation country: China Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Large Granular Lymphocytic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Middle aged Language: En Journal: Ann Med Journal subject: MEDICINA Year: 2023 Document type: Article Affiliation country: China Country of publication: Reino Unido